SinoMab BioScience Limited

SinoMab BioScience Limitedverified

3681.HK

Price:

$1.48

Market Cap:

$1.61B

SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is in Phase II clinical trial for the treat...[Read more]

Industry

Biotechnology

IPO Date

2019-11-12

Stock Exchange

HKSE

Ticker

3681.HK

The ROE as of December 2025 (TTM) for SinoMab BioScience Limited (3681.HK) is -66.18%

According to SinoMab BioScience Limited’s latest financial reports and current stock price. The company's current ROE is -66.18%. This represents a change of 90.34% compared to the average of -34.77% of the last 4 quarters.

SinoMab BioScience Limited (3681.HK) Historical ROE (quarterly & annually)

How has 3681.HK ROE performed in the past?

The mean historical ROE of SinoMab BioScience Limited over the last ten years is -65.54%. The current -66.18% ROE has changed 0.98% with respect to the historical average. Over the past ten years (40 quarters), 3681.HK's ROE was at its highest in in the December 2017 quarter at 41.02%. The ROE was at its lowest in in the December 2018 quarter at -252.03%.

Quarterly (TTM)
Annual

Average

-65.54%

Median

-49.07%

Minimum

-305.08%

Maximum

94.16%

SinoMab BioScience Limited (3681.HK) ROE by Quarter and Year

Discovering the peaks and valleys of SinoMab BioScience Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 241.09%

Maximum Annual ROE = 94.16%

Minimum Annual Increase = -424.02%

Minimum Annual ROE = -305.08%

Quarterly (TTM)
Annual
YearROEChange
2024-95.97%16.69%
2023-82.25%47.49%
2022-55.76%31.62%
2021-42.37%241.09%
2020-12.42%-49.54%
2019-24.61%-91.93%
2018-305.08%-424.02%

SinoMab BioScience Limited (3681.HK) Average ROE

How has 3681.HK ROE performed in the past?

The current ROE of SinoMab BioScience Limited (3681.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-77.99%

5-year avg

-57.75%

10-year avg

-65.54%

SinoMab BioScience Limited (3681.HK) ROE vs. Peers

How is 3681.HK’s ROE compared to its peers?

SinoMab BioScience Limited’s ROE is less than HighTide Therapeutics Inc (-0.08%), greater than Mabpharm Limited (-29.27%), greater than Shanghai Bio-heart Biological Technology Co., Ltd. (-15.70%), greater than Cutia Therapeutics (-54.56%), less than Immunotech Biopharm Ltd (287.10%), greater than Zhaoke Ophthalmology Limited (-15.44%), greater than 3D Medicines Inc. (-22.45%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), less than Frontage Holdings Corporation (1.14%), greater than C-MER Medical Holdings Limited (-6.56%),

Build a custom stock screener for SinoMab BioScience Limited (3681.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SinoMab BioScience Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SinoMab BioScience Limited (3681.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SinoMab BioScience Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is SinoMab BioScience Limited's ROE?

How is the ROE calculated for SinoMab BioScience Limited (3681.HK)?

What is the highest ROE for SinoMab BioScience Limited (3681.HK)?

What is the 3-year average ROE for SinoMab BioScience Limited (3681.HK)?

What is the 5-year average ROE for SinoMab BioScience Limited (3681.HK)?

How does the current ROE for SinoMab BioScience Limited (3681.HK) compare to its historical average?